Eric Lefkofsky: A Key Player in the Fight Against Cancer

Published / by TheRugbyUnion

Eric Lefkofsky is the co-founder and partner of Lightbank. He also founded Tempus, a tech company that uses an operating system to fight cancer. He currently serves as its CEO.

In addition, Lefkofsky co-chairs the Lefkofsky Family Foundation with Liz Lefkofsky, his wife, to promote effective strategies that improve lives in under served communities. The foundation has helped to bankroll more than 50 organizations. As if he weren’t busy enough, Eric is a trustee of Lurie Children’s Hospital in Chicago, and other important institutions.

Lefkofsky is the Chairman of the Board of Trustees of Chicago’s prestigious Steppenwolf Theatre Company. Lefkofsky has taught at the University of Chicago and authored a book entitled, “Accelerated Disruption: Understanding the True Speed of Innovation.” Eric Lefkofsky graduated from the University of Michigan.

Lefkofsky has been focused lately on the devastating effects of the dreaded disease of cancer. He believes that one of the biggest culprits is the waste of a trillion dollars in healthcare. Lefkofsky believes that if we were more sagacious with our use of funding, we could eliminate poverty, save over a million productive Americans from dying, adding more financial muscle to our economy, and enabling us to find a cure for cancer.

Lefkofsky’s company Tempus, recently raised another $200 million for cancer research. Tempus has collaborated with several of the country’s largest cancer-treatment facilities. The company offers genomic-sequencing exams for cancer patients from its own laboratories, as well as data-analysis that assists doctors in determining which exact treatments work best for each individual patient.

Tempus has been effective because it has built a plan of action to compile, organize, optimize, and analyze clinical data that can be used to understand more about cancer and how best to combat it. Lefkofsky states that his goal in the fight against cancer, is to aid doctors in creating specific treatments for each patient.